The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Macimorelin as a Diagnostic Test for Adult GH Deficiency
Abstract
Purpose: The diagnosis of adult GH deficiency (AGHD) is challenging and often requires confirmation with a GH stimulation test (GHST). The insulin tolerance test (ITT) is considered the reference standard GHST but is labor intensive, can cause severe hypoglycemia, and is contraindicated for certain patients. Macimorelin, an orally active GH secretagogue, could be used to diagnose AGHD by measuring stimulated GH levels after an oral dose. Materials and Methods: The present multicenter, open-label, randomized, two-way crossover trial was designed to validate the efficacy and safety of single-dose oral macimorelin for AGHD diagnosis compared with the ITT. Subjects with high (n = 38), intermediate (n = 37), and low (n = 39) likelihood for AGHD and healthy, matched controls (n = 25) were included in the efficacy analysis. Results: After the first test, 99% of macimorelin tests and 82% of ITTs were evaluable. Using GH cutoff levels of 2.8 ng/mL for macimorelin and 5.1 ng/mL for ITTs, the negative agreement was 95.38% (95% CI, 87% to 99%), the positive agreement was 74.32% (95% CI, 63% to 84%), sensitivity was 87%, and specificity was 96%. On retesting, the reproducibility was 97% for macimorelin (n = 33). In post hoc analyses, a GH cutoff of 5.1 ng/mL for both tests resulted in 94% (95% CI, 85% to 98%) negative agreement, 82% (95% CI, 72% to 90%) positive agreement, 92% sensitivity, and 96% specificity. No serious adverse events were reported for macimorelin. Conclusions: Oral macimorelin is a simple, well-tolerated, reproducible, and safe diagnostic test for AGHD with accuracy comparable to that of the ITT. A GH cutoff of 5.1 ng/mL for the macimorelin test provides an excellent balance between sensitivity and specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The original approval listed a cutoff value of 2.8 μg/L, but a higher cutoff value of 5.1 μg/L was subsequently demonstrated to increase GHD detection sensitivity.76,85”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034
Self-citationSensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423
Self-citationYuen, K. C. J., Tritos, N. A., Samson, S. L., Hoffman, A. R., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161407.dscr · Cited by 73 · cited 1×
“, nausea, vomiting), and has questionable diagnostic accuracy in overweight and obese patients (31).”
BackgroundSelf-citation
Research works printed but not linked: 26
- Woodhouse, 1999, Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults, J Clin Endocrinol Metab, 84, 4570
- Biller, 2000, Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency, J Clin Endocrinol Metab, 85, 970
- Attanasio, 2002, Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients, J Clin Endocrinol Metab, 87, 3368, 10.1210/jcem.87.7.8593 · DOI
- Hoffman, 2004, Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial, J Clin Endocrinol Metab, 89, 2048, 10.1210/jc.2003-030346 · DOI · Paper page
- Bollerslev, 2006, Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency, Eur J Endocrinol, 154, 537, 10.1530/eje.1.02125 · DOI
- Yuen KC . Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives. ISRN Endocrinol. 2011; 2011:608056. · DOI
- Yuen, 2013, Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults, Pituitary, 16, 220, 10.1007/s11102-012-0407-7 · DOI
- Gnanapavan, 2002, The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans, J Clin Endocrinol Metab, 87, 2988, 10.1210/jcem.87.6.8739 · DOI · Paper page
- Piccoli, 2007, Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects, J Clin Endocrinol Metab, 92, 1814, 10.1210/jc.2006-2160 · DOI
- Garcia, 2013, Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency, J Clin Endocrinol Metab, 98, 2422, 10.1210/jc.2013-1157 · DOI
- Manolopoulou, 2012, Automated 22-kD growth hormone-specific assay without interference from Pegvisomant, Clin Chem, 58, 1446, 10.1373/clinchem.2012.188128 · DOI
- Bidlingmaier, 2014, Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations, J Clin Endocrinol Metab, 99, 1712, 10.1210/jc.2013-3059 · DOI · Paper page
- Clemmons, 2011, Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays, Clin Chem, 57, 555, 10.1373/clinchem.2010.150631 · DOI · Paper page
- Tobi, 2005, Small proportions: what to report for confidence intervals, Pharmacoepidemiol Drug Saf, 14, 239, 10.1002/pds.1081 · DOI
- Indik, 2006, Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval, Heart Rhythm, 3, 1003, 10.1016/j.hrthm.2006.05.023 · DOI · Paper page
- Yuen, 2009, Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency, J Clin Endocrinol Metab, 94, 2702, 10.1210/jc.2009-0299 · DOI
- Gasco, 2012, Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults, Eur J Endocrinol, 168, 23, 10.1530/EJE-12-0584 · DOI
- Korbonits, 1999, Hexarelin as a test of pituitary reserve in patients with pituitary disease, Clin Endocrinol (Oxf), 51, 369, 10.1046/j.1365-2265.1999.00828.x · DOI
- Petersenn, 2002, Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test, Eur J Endocrinol, 146, 667, 10.1530/eje.0.1460667 · DOI
- Broglio, 2002, EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man, J Endocrinol Invest, 25, RC26, 10.1007/BF03345096 · DOI
- Chanson, 2010, Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations, J Clin Endocrinol Metab, 95, 3684, 10.1210/jc.2010-0295 · DOI
- Hoeck, 1999, Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults, Growth Horm IGF Res, 9, 18, 10.1054/ghir.1998.0085 · DOI
- Lissett, 1999, How many tests are required to diagnose growth hormone (GH) deficiency in adults, Clin Endocrinol (Oxf), 51, 551, 10.1046/j.1365-2265.1999.00836.x · DOI
- Hartman, 2002, Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency, J Clin Endocrinol Metab, 87, 477, 10.1210/jcem.87.2.8216 · DOI · Paper page
- Marcum, 2012, FDA drug safety communications: a narrative review and clinical considerations for older adults, Am J Geriatr Pharmacother, 10, 264, 10.1016/j.amjopharm.2012.05.002 · DOI · Paper page
- Kacheva, 2017, QT prolongation caused by insulin-induced hypoglycaemia—an interventional study in 119 individuals, Diabetes Res Clin Pract, 123, 165, 10.1016/j.diabres.2016.11.021 · DOI
Cited by
Collett-Solberg, P. F., Ambler, G., Backeljauw, P. F., Bidlingmaier, M., Biller, B. M. K., Boguszewski, M. C. S., Cheung, P. T., Choong, C. S. Y., Cohen, L. E., Cohen, P., et al. (2019) · Hormone Research in Paediatrics · doi:10.1159/000502231 · Cited by 360
Self-citationYuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Self-citationWexler, T. L., Reifschneider, K., Backeljauw, P., Cárdenas, J. F., Hoffman, A. R., Miller, B. S., & Yuen, K. C. J. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0384 · Cited by 19
Self-citationExperience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury
Lee, J., Anderson, L. J., Migula, D., Yuen, K. C. J., McPeak, L., & Garcia, J. M. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab005 · Cited by 17
Self-citation
Metadata
- Authors
- Garcia, J. M., Biller, B. M. K., Korbonits, M., Popovic, V., Luger, A., Strasburger, C. J., Chanson, P., Medic-Stojanoska, M., Schopohl, J., Zakrzewska, A., Pekic, S., Bolanowski, M., Swerdloff, R., Wang, C., Blevins, T., Marcelli, M., Ammer, N., Sachse, R., & Yuen, K. C. J.
- Affiliations
- Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, University of Washington and SIBCR, Seattle, Washington
- Massachusetts General Hospital, Boston, Massachusetts
- Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom
- University of Belgrade Faculty of Medicine, Belgrade, Serbia
- Vienna General Hospital – Medical University Campus, Vienna, Austria
- Charité – Universitatsmedizin, Berlin, Germany
- Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
- University of Novi Sad, Faculty of Medicine, Clinical Center of Vojvodina, Novi Sad, Serbia
- Medizinische Klinik IV, Ludwig Maximilian University of Munich, Munich, Germany
- Angelius Provita Medical Center, Katowice, Poland
- WroMedica, Wrocław, Poland
- Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California
- Texas Diabetes and Endocrinology, Austin, Texas
- Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
- Aeterna Zentaris GmbH, Frankfurt, Germany
- Swedish Neuroscience Institute, Seattle, Washington
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-05-31
- Volume
- 103
- Issue
- 8
- Pages
- 3083-3093
- ISSN
- 0021-972X
- 1945-7197
- Cited by
- 105
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Macimorelin as a Diagnostic Test for Adult GH Deficiency. https://app.cochat.ai/papers/10.1210/jc.2018-00665
- The paper
- Garcia, J. M., Biller, B. M. K., Korbonits, M., Popovic, V., Luger, A., Strasburger, C. J., Chanson, P., Medic-Stojanoska, M., Schopohl, J., Zakrzewska, A., Pekic, S., Bolanowski, M., Swerdloff, R., Wang, C., Blevins, T., Marcelli, M., Ammer, N., Sachse, R., & Yuen, K. C. J. (2018). Macimorelin as a Diagnostic Test for Adult GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-00665
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.